Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Affiliations

¹ GlaxoSmithKline, Avenue Fleming, 20, Wavre B1300, Belgium. Electronic address: Paul.gillard@gsk.com.
² GlaxoSmithKline, Avenue Fleming, 20, Wavre B1300, Belgium. Electronic address: Bernd.x.benninghoff@gsk.com.

Comment

P Gillard et al. Vaccine. 2019.

. 2019 May 21;37(23):2990.

doi: 10.1016/j.vaccine.2019.04.003.

¹ GlaxoSmithKline, Avenue Fleming, 20, Wavre B1300, Belgium. Electronic address: Paul.gillard@gsk.com.
² GlaxoSmithKline, Avenue Fleming, 20, Wavre B1300, Belgium. Electronic address: Bernd.x.benninghoff@gsk.com.

No abstract available

Comment in

Response to: Letter from P. Gillard and B. Benninghoff.
Rathi N, Desai S, Kawade A, Venkatramanan P, Kundu R, Lalwani SK, Dubey AP, Venkateswara Rao J, Narayanappa D, Ghildiyal R, Gogtay NJ, Venugopal P, Palkar S, Munshi R, Kang G, Babji S, Bavdekar A, Juvekar S, Ganguly N, Niyogi P, Uttam KG, Rajani HS, Kondekar A, Kumbhar D, Mohanlal S, Agarwal MC, Shetty P, Antony K, Gunale B, Dharmadhikari A, Tang Y, Kulkarni PS, Flores J. Rathi N, et al. Vaccine. 2019 May 21;37(23):2991-2992. doi: 10.1016/j.vaccine.2019.04.002. Vaccine. 2019. PMID: 31072468 No abstract available.

A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Rathi N, Desai S, Kawade A, Venkatramanan P, Kundu R, Lalwani SK, Dubey AP, Venkateswara Rao J, Narayanappa D, Ghildiyal R, Gogtay N, Venugopal P, Palkar S, Munshi R, Kang G, Babji S, Bavdekar A, Juvekar S, Ganguly N, Niyogi P, Ghosh Uttam K, Rajani HS, Kondekar A, Kumbhar D, Mohanlal S, Agarwal MC, Shetty P, Antony K, Gunale B, Dharmadhikari A, Tang Y, Kulkarni PS, Flores J. Rathi N, et al. Vaccine. 2018 Dec 18;36(52):7943-7949. doi: 10.1016/j.vaccine.2018.11.006. Epub 2018 Nov 9. Vaccine. 2018. PMID: 30420116 Free PMC article. Clinical Trial.